Lancet (London, England) investigators, ISARICC & Dark, P 2021, ' Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study. ', Lancet (London, England), vol. 398, no. 10296, pp. 223-237 . https://doi.org/10.1016/S0140-6736(21)00799-6 The Lancet The Lancet, Elsevier, 2021, 398 (10296), pp.223-237. ⟨10.1016/S0140-6736(21)00799-6⟩ Drake, T, Riad, A M, Fairfield, C J, Egan, C, Knight, S, Pius, R, Hardwick, H E, Norman, L, Shaw, K, Mclean, K, Docherty, A B & Harrison, E M 2021, ' Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK : A prospective, multicentre cohort study ', The Lancet, vol. 398, no. 10296 . https://doi.org/10.1016/S0140-6736(21)00799-6
2021, ' Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study : a multicentre, prospective cohort study ', The Lancet Microbe . https://doi.org/10.1016/S2666-5247(21)00090-2 LANCET MICROBE The Lancet Microbe E365 E354 investigators, ISARICC & Dark, P 2021, ' Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study. ', The Lancet. Microbe, vol. 2, no. 8, pp. e354-e365 . https://doi.org/10.1016/S2666-5247(21)00090-2 The Lancet. Microbe